nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—migraine—Prednisone—psoriatic arthritis	0.623	1	CpDpCtD
Caffeine—CYP1B1—Dexamethasone—psoriatic arthritis	0.0453	0.165	CbGbCtD
Caffeine—ABCB1—Methylprednisolone—psoriatic arthritis	0.0205	0.0749	CbGbCtD
Caffeine—CYP1A1—Dexamethasone—psoriatic arthritis	0.0199	0.0725	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0159	0.058	CbGbCtD
Caffeine—CYP3A7—Dexamethasone—psoriatic arthritis	0.0159	0.058	CbGbCtD
Caffeine—CYP2E1—Dexamethasone—psoriatic arthritis	0.0154	0.056	CbGbCtD
Caffeine—ABCB1—Betamethasone—psoriatic arthritis	0.0134	0.0487	CbGbCtD
Caffeine—ABCB1—Prednisolone—psoriatic arthritis	0.0132	0.048	CbGbCtD
Caffeine—ABCB1—Prednisone—psoriatic arthritis	0.0124	0.0454	CbGbCtD
Caffeine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0123	0.0449	CbGbCtD
Caffeine—CYP3A5—Dexamethasone—psoriatic arthritis	0.0119	0.0435	CbGbCtD
Caffeine—CYP2C8—Dexamethasone—psoriatic arthritis	0.0115	0.0418	CbGbCtD
Caffeine—CYP3A4—Triamcinolone—psoriatic arthritis	0.00932	0.034	CbGbCtD
Caffeine—Retinopathy of prematurity—Dexamethasone—psoriatic arthritis	0.00848	0.143	CcSEcCtD
Caffeine—Retinopathy of prematurity—Betamethasone—psoriatic arthritis	0.00848	0.143	CcSEcCtD
Caffeine—CYP2C9—Dexamethasone—psoriatic arthritis	0.008	0.0292	CbGbCtD
Caffeine—CYP3A4—Betamethasone—psoriatic arthritis	0.008	0.0292	CbGbCtD
Caffeine—CYP3A4—Prednisolone—psoriatic arthritis	0.00789	0.0288	CbGbCtD
Caffeine—ABCB1—Dexamethasone—psoriatic arthritis	0.00777	0.0283	CbGbCtD
Caffeine—CYP3A4—Prednisone—psoriatic arthritis	0.00745	0.0272	CbGbCtD
Caffeine—CYP2D6—Dexamethasone—psoriatic arthritis	0.00732	0.0267	CbGbCtD
Caffeine—ABCB1—Methotrexate—psoriatic arthritis	0.00624	0.0228	CbGbCtD
Caffeine—CYP3A4—Dexamethasone—psoriatic arthritis	0.00465	0.017	CbGbCtD
Caffeine—Ca++ increased—Methylprednisolone—psoriatic arthritis	0.00448	0.0753	CcSEcCtD
Caffeine—PIK3CA—Atypical NF-kappaB pathway—REL—psoriatic arthritis	0.0022	0.0548	CbGpPWpGaD
Caffeine—PIK3CA—IL23-mediated signaling events—IL23R—psoriatic arthritis	0.00214	0.0533	CbGpPWpGaD
Caffeine—PIK3CA—IL2 signaling events mediated by STAT5—LTA—psoriatic arthritis	0.00197	0.049	CbGpPWpGaD
Caffeine—PIK3CA—IL23-mediated signaling events—IL23A—psoriatic arthritis	0.00182	0.0453	CbGpPWpGaD
Caffeine—ATM—Canonical NF-kappaB pathway—NOD2—psoriatic arthritis	0.00162	0.0403	CbGpPWpGaD
Caffeine—Impaired healing—Prednisolone—psoriatic arthritis	0.00142	0.0238	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Auranofin—psoriatic arthritis	0.00139	0.0234	CcSEcCtD
Caffeine—Impaired healing—Triamcinolone—psoriatic arthritis	0.0013	0.0219	CcSEcCtD
Caffeine—Impaired healing—Methylprednisolone—psoriatic arthritis	0.0013	0.0218	CcSEcCtD
Caffeine—PIK3CD—Overview of nanoparticle effects—CRP—psoriatic arthritis	0.00121	0.0301	CbGpPWpGaD
Caffeine—Impaired healing—Dexamethasone—psoriatic arthritis	0.00118	0.0199	CcSEcCtD
Caffeine—Impaired healing—Betamethasone—psoriatic arthritis	0.00118	0.0199	CcSEcCtD
Caffeine—PRKDC—Testosterone—Prednisolone—psoriatic arthritis	0.00118	0.546	CbGdCrCtD
Caffeine—PIK3CA—IL4-mediated signaling events—LTA—psoriatic arthritis	0.0011	0.0274	CbGpPWpGaD
Caffeine—PIK3CD—Interferon type I signaling pathways—REL—psoriatic arthritis	0.00109	0.0271	CbGpPWpGaD
Caffeine—Impaired healing—Prednisone—psoriatic arthritis	0.00103	0.0173	CcSEcCtD
Caffeine—PRKDC—Danazol—Prednisone—psoriatic arthritis	0.000979	0.454	CbGdCrCtD
Caffeine—Impaired healing—Methotrexate—psoriatic arthritis	0.000859	0.0145	CcSEcCtD
Caffeine—PIK3CA—IL23-mediated signaling events—IL17A—psoriatic arthritis	0.000851	0.0212	CbGpPWpGaD
Caffeine—Hypercalcaemia—Methylprednisolone—psoriatic arthritis	0.000808	0.0136	CcSEcCtD
Caffeine—PIK3CA—IL23-mediated signaling events—IL12B—psoriatic arthritis	0.000792	0.0197	CbGpPWpGaD
Caffeine—PIK3CD—Overview of nanoparticle effects—TNF—psoriatic arthritis	0.000547	0.0136	CbGpPWpGaD
Caffeine—PIK3CB—Downstream TCR signaling—HLA-DRB1—psoriatic arthritis	0.000545	0.0136	CbGpPWpGaD
Caffeine—Pulmonary oedema—Prednisolone—psoriatic arthritis	0.000545	0.00916	CcSEcCtD
Caffeine—ATM—Canonical NF-kappaB pathway—TNF—psoriatic arthritis	0.000521	0.013	CbGpPWpGaD
Caffeine—PIK3CD—Toll-like Receptor Signaling Pathway—IL12B—psoriatic arthritis	0.000512	0.0128	CbGpPWpGaD
Caffeine—Pulmonary oedema—Triamcinolone—psoriatic arthritis	0.000501	0.00843	CcSEcCtD
Caffeine—Pulmonary oedema—Methylprednisolone—psoriatic arthritis	0.0005	0.00841	CcSEcCtD
Caffeine—Injury—Prednisolone—psoriatic arthritis	0.000483	0.00813	CcSEcCtD
Caffeine—PRKDC—Innate Immune System—MEFV—psoriatic arthritis	0.000459	0.0114	CbGpPWpGaD
Caffeine—Pulmonary oedema—Dexamethasone—psoriatic arthritis	0.000455	0.00765	CcSEcCtD
Caffeine—Pulmonary oedema—Betamethasone—psoriatic arthritis	0.000455	0.00765	CcSEcCtD
Caffeine—PRKDC—FAS pathway and Stress induction of HSP regulation—TNF—psoriatic arthritis	0.000453	0.0113	CbGpPWpGaD
Caffeine—PIK3CB—Toll-like Receptor Signaling Pathway—IL12B—psoriatic arthritis	0.000446	0.0111	CbGpPWpGaD
Caffeine—Injury—Triamcinolone—psoriatic arthritis	0.000444	0.00748	CcSEcCtD
Caffeine—PIK3CA—IL23-mediated signaling events—NOS2—psoriatic arthritis	0.000444	0.0111	CbGpPWpGaD
Caffeine—Injury—Methylprednisolone—psoriatic arthritis	0.000443	0.00746	CcSEcCtD
Caffeine—PIK3CD—Downstream signaling events of B Cell Receptor (BCR)—REL—psoriatic arthritis	0.000441	0.011	CbGpPWpGaD
Caffeine—Rash—Auranofin—psoriatic arthritis	0.000432	0.00726	CcSEcCtD
Caffeine—Dermatitis—Auranofin—psoriatic arthritis	0.000431	0.00726	CcSEcCtD
Caffeine—PIK3CA—Downstream TCR signaling—HLA-DRB1—psoriatic arthritis	0.000429	0.0107	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by Interleukins—NOD2—psoriatic arthritis	0.000423	0.0105	CbGpPWpGaD
Caffeine—Dry skin—Prednisolone—psoriatic arthritis	0.000407	0.00685	CcSEcCtD
Caffeine—PIK3CB—TCR signaling—HLA-DRB1—psoriatic arthritis	0.000407	0.0101	CbGpPWpGaD
Caffeine—Injury—Dexamethasone—psoriatic arthritis	0.000403	0.00678	CcSEcCtD
Caffeine—Injury—Betamethasone—psoriatic arthritis	0.000403	0.00678	CcSEcCtD
Caffeine—PIK3CA—IL6-mediated signaling events—CRP—psoriatic arthritis	0.000402	0.01	CbGpPWpGaD
Caffeine—PIK3CD—Regulation of toll-like receptor signaling pathway—IL12B—psoriatic arthritis	0.0004	0.00996	CbGpPWpGaD
Caffeine—Pulmonary oedema—Prednisone—psoriatic arthritis	0.000396	0.00666	CcSEcCtD
Caffeine—PIK3CD—B Cell Activation—REL—psoriatic arthritis	0.00039	0.00971	CbGpPWpGaD
Caffeine—Irritability—Methylprednisolone—psoriatic arthritis	0.000389	0.00654	CcSEcCtD
Caffeine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriatic arthritis	0.000388	0.00967	CbGpPWpGaD
Caffeine—PIK3CD—DAP12 interactions—HLA-C—psoriatic arthritis	0.000387	0.00965	CbGpPWpGaD
Caffeine—Sepsis—Prednisone—psoriatic arthritis	0.000386	0.00649	CcSEcCtD
Caffeine—PIK3CB—Downstream signaling events of B Cell Receptor (BCR)—REL—psoriatic arthritis	0.000384	0.00958	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by Interleukins—NOD2—psoriatic arthritis	0.000369	0.00919	CbGpPWpGaD
Caffeine—Irritability—Dexamethasone—psoriatic arthritis	0.000354	0.00595	CcSEcCtD
Caffeine—Irritability—Betamethasone—psoriatic arthritis	0.000354	0.00595	CcSEcCtD
Caffeine—PIK3CA—Toll-like Receptor Signaling Pathway—IL12B—psoriatic arthritis	0.000352	0.00876	CbGpPWpGaD
Caffeine—Injury—Prednisone—psoriatic arthritis	0.000351	0.00591	CcSEcCtD
Caffeine—PIK3CB—Regulation of toll-like receptor signaling pathway—IL12B—psoriatic arthritis	0.000348	0.00868	CbGpPWpGaD
Caffeine—Dry skin—Betamethasone—psoriatic arthritis	0.00034	0.00572	CcSEcCtD
Caffeine—Dry skin—Dexamethasone—psoriatic arthritis	0.00034	0.00572	CcSEcCtD
Caffeine—PIK3CB—B Cell Activation—REL—psoriatic arthritis	0.00034	0.00846	CbGpPWpGaD
Caffeine—PIK3CB—DAP12 interactions—HLA-C—psoriatic arthritis	0.000338	0.00841	CbGpPWpGaD
Caffeine—Urine output increased—Methotrexate—psoriatic arthritis	0.000336	0.00565	CcSEcCtD
Caffeine—Pulmonary oedema—Methotrexate—psoriatic arthritis	0.000331	0.00556	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Prednisone—psoriatic arthritis	0.000323	0.00543	CcSEcCtD
Caffeine—Sepsis—Methotrexate—psoriatic arthritis	0.000323	0.00543	CcSEcCtD
Caffeine—PIK3CA—TCR signaling—HLA-DRB1—psoriatic arthritis	0.000321	0.00799	CbGpPWpGaD
Caffeine—Infestation—Methylprednisolone—psoriatic arthritis	0.000314	0.00528	CcSEcCtD
Caffeine—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.000314	0.00528	CcSEcCtD
Caffeine—Haemoglobin—Prednisolone—psoriatic arthritis	0.000309	0.0052	CcSEcCtD
Caffeine—Irritability—Prednisone—psoriatic arthritis	0.000308	0.00518	CcSEcCtD
Caffeine—Haemorrhage—Prednisolone—psoriatic arthritis	0.000307	0.00517	CcSEcCtD
Caffeine—PIK3CB—CXCR4-mediated signaling events—HLA-DRB1—psoriatic arthritis	0.000307	0.00765	CbGpPWpGaD
Caffeine—PIK3CA—Downstream signaling events of B Cell Receptor (BCR)—REL—psoriatic arthritis	0.000303	0.00755	CbGpPWpGaD
Caffeine—Dry skin—Prednisone—psoriatic arthritis	0.000296	0.00498	CcSEcCtD
Caffeine—PIK3CD—Innate Immune System—MEFV—psoriatic arthritis	0.000294	0.00733	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by Interleukins—NOD2—psoriatic arthritis	0.000291	0.00724	CbGpPWpGaD
Caffeine—Hyperglycaemia—Dexamethasone—psoriatic arthritis	0.000289	0.00486	CcSEcCtD
Caffeine—Hyperglycaemia—Betamethasone—psoriatic arthritis	0.000289	0.00486	CcSEcCtD
Caffeine—PIK3CA—Costimulation by the CD28 family—HLA-DRB1—psoriatic arthritis	0.000286	0.00713	CbGpPWpGaD
Caffeine—Haemoglobin—Triamcinolone—psoriatic arthritis	0.000284	0.00478	CcSEcCtD
Caffeine—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.000283	0.00477	CcSEcCtD
Caffeine—Haemorrhage—Triamcinolone—psoriatic arthritis	0.000283	0.00475	CcSEcCtD
Caffeine—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.000282	0.00474	CcSEcCtD
Caffeine—PIK3CA—Rac1/Pak1/p38/MMP-2 pathway—NOS2—psoriatic arthritis	0.000276	0.00687	CbGpPWpGaD
Caffeine—PIK3CA—Regulation of toll-like receptor signaling pathway—IL12B—psoriatic arthritis	0.000275	0.00684	CbGpPWpGaD
Caffeine—PIK3CD—Cytokine Signaling in Immune system—HLA-C—psoriatic arthritis	0.000268	0.00669	CbGpPWpGaD
Caffeine—PIK3CA—B Cell Activation—REL—psoriatic arthritis	0.000268	0.00667	CbGpPWpGaD
Caffeine—PRKDC—Immune System—MEFV—psoriatic arthritis	0.000268	0.00667	CbGpPWpGaD
Caffeine—PIK3CA—DAP12 interactions—HLA-C—psoriatic arthritis	0.000266	0.00663	CbGpPWpGaD
Caffeine—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.000262	0.0044	CcSEcCtD
Caffeine—PRKDC—Circadian rythm related genes—NOS2—psoriatic arthritis	0.000261	0.00649	CbGpPWpGaD
Caffeine—Haemoglobin—Betamethasone—psoriatic arthritis	0.000258	0.00434	CcSEcCtD
Caffeine—Haemoglobin—Dexamethasone—psoriatic arthritis	0.000258	0.00434	CcSEcCtD
Caffeine—Irritability—Methotrexate—psoriatic arthritis	0.000257	0.00433	CcSEcCtD
Caffeine—Haemorrhage—Dexamethasone—psoriatic arthritis	0.000256	0.00431	CcSEcCtD
Caffeine—Haemorrhage—Betamethasone—psoriatic arthritis	0.000256	0.00431	CcSEcCtD
Caffeine—PIK3CB—Innate Immune System—MEFV—psoriatic arthritis	0.000256	0.00639	CbGpPWpGaD
Caffeine—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000255	0.00428	CcSEcCtD
Caffeine—Hyperglycaemia—Prednisone—psoriatic arthritis	0.000252	0.00423	CcSEcCtD
Caffeine—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000245	0.00413	CcSEcCtD
Caffeine—PIK3CA—CXCR4-mediated signaling events—HLA-DRB1—psoriatic arthritis	0.000242	0.00602	CbGpPWpGaD
Caffeine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriatic arthritis	0.000239	0.00595	CbGpPWpGaD
Caffeine—PRKDC—Innate Immune System—HLA-C—psoriatic arthritis	0.000235	0.00586	CbGpPWpGaD
Caffeine—PIK3CB—Cytokine Signaling in Immune system—HLA-C—psoriatic arthritis	0.000234	0.00583	CbGpPWpGaD
Caffeine—Convulsion—Prednisolone—psoriatic arthritis	0.000232	0.0039	CcSEcCtD
Caffeine—Hypertension—Prednisolone—psoriatic arthritis	0.000231	0.00389	CcSEcCtD
Caffeine—PIK3CD—DAP12 interactions—HLA-B—psoriatic arthritis	0.000229	0.00571	CbGpPWpGaD
Caffeine—Haemoglobin—Prednisone—psoriatic arthritis	0.000224	0.00378	CcSEcCtD
Caffeine—Haemorrhage—Prednisone—psoriatic arthritis	0.000223	0.00376	CcSEcCtD
Caffeine—PIK3CA—IL23-mediated signaling events—TNF—psoriatic arthritis	0.00022	0.00549	CbGpPWpGaD
Caffeine—Convulsion—Triamcinolone—psoriatic arthritis	0.000213	0.00359	CcSEcCtD
Caffeine—Tachycardia—Prednisolone—psoriatic arthritis	0.000213	0.00358	CcSEcCtD
Caffeine—Convulsion—Methylprednisolone—psoriatic arthritis	0.000213	0.00358	CcSEcCtD
Caffeine—Hypertension—Triamcinolone—psoriatic arthritis	0.000212	0.00357	CcSEcCtD
Caffeine—Hypertension—Methylprednisolone—psoriatic arthritis	0.000212	0.00356	CcSEcCtD
Caffeine—Infestation NOS—Methotrexate—psoriatic arthritis	0.000208	0.0035	CcSEcCtD
Caffeine—Infestation—Methotrexate—psoriatic arthritis	0.000208	0.0035	CcSEcCtD
Caffeine—Renal failure—Methotrexate—psoriatic arthritis	0.000204	0.00344	CcSEcCtD
Caffeine—ADORA2A—Monoamine Transport—TNF—psoriatic arthritis	0.000204	0.00509	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—MEFV—psoriatic arthritis	0.000202	0.00503	CbGpPWpGaD
Caffeine—Immune system disorder—Prednisone—psoriatic arthritis	0.000202	0.00339	CcSEcCtD
Caffeine—PIK3CB—DAP12 interactions—HLA-B—psoriatic arthritis	0.0002	0.00498	CbGpPWpGaD
Caffeine—Infection—Triamcinolone—psoriatic arthritis	0.000199	0.00336	CcSEcCtD
Caffeine—Infection—Methylprednisolone—psoriatic arthritis	0.000199	0.00335	CcSEcCtD
Caffeine—PIK3CD—Cytokine Signaling in Immune system—NOD2—psoriatic arthritis	0.000197	0.00492	CbGpPWpGaD
Caffeine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000196	0.0033	CcSEcCtD
Caffeine—Tachycardia—Triamcinolone—psoriatic arthritis	0.000196	0.0033	CcSEcCtD
Caffeine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000196	0.00329	CcSEcCtD
Caffeine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000195	0.00327	CcSEcCtD
Caffeine—Malnutrition—Prednisone—psoriatic arthritis	0.000194	0.00327	CcSEcCtD
Caffeine—Convulsion—Dexamethasone—psoriatic arthritis	0.000193	0.00325	CcSEcCtD
Caffeine—Convulsion—Betamethasone—psoriatic arthritis	0.000193	0.00325	CcSEcCtD
Caffeine—Hypertension—Betamethasone—psoriatic arthritis	0.000193	0.00324	CcSEcCtD
Caffeine—Hypertension—Dexamethasone—psoriatic arthritis	0.000193	0.00324	CcSEcCtD
Caffeine—Haemoglobin—Methotrexate—psoriatic arthritis	0.000188	0.00316	CcSEcCtD
Caffeine—Haemorrhage—Methotrexate—psoriatic arthritis	0.000187	0.00314	CcSEcCtD
Caffeine—PIK3CA—Cytokine Signaling in Immune system—HLA-C—psoriatic arthritis	0.000184	0.00459	CbGpPWpGaD
Caffeine—Infection—Dexamethasone—psoriatic arthritis	0.000181	0.00304	CcSEcCtD
Caffeine—Infection—Betamethasone—psoriatic arthritis	0.000181	0.00304	CcSEcCtD
Caffeine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000179	0.00301	CcSEcCtD
Caffeine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000179	0.00301	CcSEcCtD
Caffeine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000179	0.00301	CcSEcCtD
Caffeine—Agitation—Prednisone—psoriatic arthritis	0.000179	0.00301	CcSEcCtD
Caffeine—Tachycardia—Betamethasone—psoriatic arthritis	0.000178	0.00299	CcSEcCtD
Caffeine—Tachycardia—Dexamethasone—psoriatic arthritis	0.000178	0.00299	CcSEcCtD
Caffeine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000173	0.00291	CcSEcCtD
Caffeine—PIK3CA—Angiopoietin receptor Tie2-mediated signaling—TNF—psoriatic arthritis	0.000173	0.00431	CbGpPWpGaD
Caffeine—PRKDC—Innate Immune System—NOD2—psoriatic arthritis	0.000173	0.00431	CbGpPWpGaD
Caffeine—PIK3CB—Cytokine Signaling in Immune system—NOD2—psoriatic arthritis	0.000172	0.00429	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—MEFV—psoriatic arthritis	0.000171	0.00427	CbGpPWpGaD
Caffeine—Immune system disorder—Methotrexate—psoriatic arthritis	0.000169	0.00284	CcSEcCtD
Caffeine—Convulsion—Prednisone—psoriatic arthritis	0.000168	0.00283	CcSEcCtD
Caffeine—Hypertension—Prednisone—psoriatic arthritis	0.000168	0.00282	CcSEcCtD
Caffeine—PIK3CD—MicroRNAs in cardiomyocyte hypertrophy—TNF—psoriatic arthritis	0.000166	0.00415	CbGpPWpGaD
Caffeine—Malnutrition—Methotrexate—psoriatic arthritis	0.000162	0.00273	CcSEcCtD
Caffeine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000161	0.00271	CcSEcCtD
Caffeine—PIK3CD—Cytokine Signaling in Immune system—HLA-B—psoriatic arthritis	0.000159	0.00395	CbGpPWpGaD
Caffeine—Infection—Prednisone—psoriatic arthritis	0.000158	0.00265	CcSEcCtD
Caffeine—PIK3CA—DAP12 interactions—HLA-B—psoriatic arthritis	0.000157	0.00392	CbGpPWpGaD
Caffeine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000157	0.00265	CcSEcCtD
Caffeine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000157	0.00265	CcSEcCtD
Caffeine—PIK3CD—Adaptive Immune System—REL—psoriatic arthritis	0.000157	0.00391	CbGpPWpGaD
Caffeine—Nervous system disorder—Prednisone—psoriatic arthritis	0.000156	0.00262	CcSEcCtD
Caffeine—Tachycardia—Prednisone—psoriatic arthritis	0.000155	0.0026	CcSEcCtD
Caffeine—Skin disorder—Prednisone—psoriatic arthritis	0.000154	0.00259	CcSEcCtD
Caffeine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriatic arthritis	0.000152	0.0038	CbGpPWpGaD
Caffeine—PIK3CD—Innate Immune System—HLA-C—psoriatic arthritis	0.000151	0.00375	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—MEFV—psoriatic arthritis	0.000149	0.00372	CbGpPWpGaD
Caffeine—PRKDC—Immune System—REL—psoriatic arthritis	0.000149	0.00371	CbGpPWpGaD
Caffeine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000148	0.00249	CcSEcCtD
Caffeine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000148	0.00248	CcSEcCtD
Caffeine—ABCB1—Allograft Rejection—HLA-C—psoriatic arthritis	0.000146	0.00363	CbGpPWpGaD
Caffeine—PIK3CB—MicroRNAs in cardiomyocyte hypertrophy—TNF—psoriatic arthritis	0.000145	0.00361	CbGpPWpGaD
Caffeine—ABCB1—Allograft Rejection—IL13—psoriatic arthritis	0.000145	0.00361	CbGpPWpGaD
Caffeine—PIK3CD—Adaptive Immune System—HLA-C—psoriatic arthritis	0.000145	0.0036	CbGpPWpGaD
Caffeine—PIK3CD—Toll-like Receptor Signaling Pathway—TNF—psoriatic arthritis	0.000142	0.00355	CbGpPWpGaD
Caffeine—Convulsion—Methotrexate—psoriatic arthritis	0.000141	0.00237	CcSEcCtD
Caffeine—PRKDC—Innate Immune System—HLA-B—psoriatic arthritis	0.000139	0.00346	CbGpPWpGaD
Caffeine—PIK3CB—Cytokine Signaling in Immune system—HLA-B—psoriatic arthritis	0.000138	0.00345	CbGpPWpGaD
Caffeine—Rash—Prednisolone—psoriatic arthritis	0.000138	0.00232	CcSEcCtD
Caffeine—Dermatitis—Prednisolone—psoriatic arthritis	0.000138	0.00231	CcSEcCtD
Caffeine—PRKDC—Immune System—HLA-C—psoriatic arthritis	0.000137	0.00341	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—REL—psoriatic arthritis	0.000137	0.00341	CbGpPWpGaD
Caffeine—PIK3CA—Cytokine Signaling in Immune system—NOD2—psoriatic arthritis	0.000136	0.00338	CbGpPWpGaD
Caffeine—PIK3CD—Cytokine Signaling in Immune system—HLA-DRB1—psoriatic arthritis	0.000134	0.00335	CbGpPWpGaD
Caffeine—ABCB1—Allograft Rejection—IL17A—psoriatic arthritis	0.000133	0.00332	CbGpPWpGaD
Caffeine—Infection—Methotrexate—psoriatic arthritis	0.000132	0.00222	CcSEcCtD
Caffeine—PIK3CB—Innate Immune System—HLA-C—psoriatic arthritis	0.000131	0.00327	CbGpPWpGaD
Caffeine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00013	0.00219	CcSEcCtD
Caffeine—Skin disorder—Methotrexate—psoriatic arthritis	0.000129	0.00217	CcSEcCtD
Caffeine—Rash—Triamcinolone—psoriatic arthritis	0.000127	0.00213	CcSEcCtD
Caffeine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000126	0.00213	CcSEcCtD
Caffeine—Rash—Methylprednisolone—psoriatic arthritis	0.000126	0.00212	CcSEcCtD
Caffeine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000126	0.00212	CcSEcCtD
Caffeine—PIK3CB—Adaptive Immune System—HLA-C—psoriatic arthritis	0.000126	0.00314	CbGpPWpGaD
Caffeine—PIK3CB—Toll-like Receptor Signaling Pathway—TNF—psoriatic arthritis	0.000124	0.00309	CbGpPWpGaD
Caffeine—ABCB1—Allograft Rejection—IL12B—psoriatic arthritis	0.000124	0.00308	CbGpPWpGaD
Caffeine—PRKDC—Innate Immune System—CRP—psoriatic arthritis	0.000123	0.00306	CbGpPWpGaD
Caffeine—ADORA1—Circadian rythm related genes—NOS2—psoriatic arthritis	0.000123	0.00305	CbGpPWpGaD
Caffeine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000118	0.00199	CcSEcCtD
Caffeine—PIK3CA—Immune System—MEFV—psoriatic arthritis	0.000118	0.00293	CbGpPWpGaD
Caffeine—PIK3CB—Cytokine Signaling in Immune system—HLA-DRB1—psoriatic arthritis	0.000117	0.00292	CbGpPWpGaD
Caffeine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000117	0.00197	CcSEcCtD
Caffeine—Rash—Dexamethasone—psoriatic arthritis	0.000115	0.00193	CcSEcCtD
Caffeine—Rash—Betamethasone—psoriatic arthritis	0.000115	0.00193	CcSEcCtD
Caffeine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000115	0.00193	CcSEcCtD
Caffeine—Dermatitis—Betamethasone—psoriatic arthritis	0.000115	0.00193	CcSEcCtD
Caffeine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000114	0.00193	CcSEcCtD
Caffeine—PIK3CA—MicroRNAs in cardiomyocyte hypertrophy—TNF—psoriatic arthritis	0.000114	0.00285	CbGpPWpGaD
Caffeine—PIK3CD—Regulation of toll-like receptor signaling pathway—TNF—psoriatic arthritis	0.000111	0.00277	CbGpPWpGaD
Caffeine—PIK3CD—Innate Immune System—NOD2—psoriatic arthritis	0.000111	0.00276	CbGpPWpGaD
Caffeine—PIK3CA—Cytokine Signaling in Immune system—HLA-B—psoriatic arthritis	0.000109	0.00272	CbGpPWpGaD
Caffeine—CYP1B1—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	0.000108	0.00269	CbGpPWpGaD
Caffeine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriatic arthritis	0.000108	0.00269	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—REL—psoriatic arthritis	0.000108	0.00269	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—HLA-C—psoriatic arthritis	0.000103	0.00258	CbGpPWpGaD
Caffeine—PRKDC—Immune System—NOD2—psoriatic arthritis	0.000101	0.00251	CbGpPWpGaD
Caffeine—Rash—Prednisone—psoriatic arthritis	0.0001	0.00168	CcSEcCtD
Caffeine—Dermatitis—Prednisone—psoriatic arthritis	9.99e-05	0.00168	CcSEcCtD
Caffeine—PIK3CA—Adaptive Immune System—HLA-C—psoriatic arthritis	9.93e-05	0.00247	CbGpPWpGaD
Caffeine—PIK3CA—Toll-like Receptor Signaling Pathway—TNF—psoriatic arthritis	9.79e-05	0.00244	CbGpPWpGaD
Caffeine—Hypersensitivity—Methotrexate—psoriatic arthritis	9.77e-05	0.00164	CcSEcCtD
Caffeine—PIK3CB—Regulation of toll-like receptor signaling pathway—TNF—psoriatic arthritis	9.7e-05	0.00242	CbGpPWpGaD
Caffeine—PIK3CB—Innate Immune System—NOD2—psoriatic arthritis	9.65e-05	0.0024	CbGpPWpGaD
Caffeine—ATM—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	9.57e-05	0.00239	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—REL—psoriatic arthritis	9.53e-05	0.00237	CbGpPWpGaD
Caffeine—ADORA2A—Circadian rythm related genes—NOS2—psoriatic arthritis	9.46e-05	0.00236	CbGpPWpGaD
Caffeine—PIK3CA—Cytokine Signaling in Immune system—HLA-DRB1—psoriatic arthritis	9.23e-05	0.0023	CbGpPWpGaD
Caffeine—ATM—skin of body—psoriatic arthritis	9.07e-05	0.139	CbGeAlD
Caffeine—PIK3CD—Innate Immune System—HLA-B—psoriatic arthritis	8.9e-05	0.00222	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—HLA-C—psoriatic arthritis	8.77e-05	0.00218	CbGpPWpGaD
Caffeine—ABCB1—Allograft Rejection—HLA-B—psoriatic arthritis	8.61e-05	0.00215	CbGpPWpGaD
Caffeine—PIK3CD—Adaptive Immune System—HLA-B—psoriatic arthritis	8.55e-05	0.00213	CbGpPWpGaD
Caffeine—Rash—Methotrexate—psoriatic arthritis	8.36e-05	0.00141	CcSEcCtD
Caffeine—Dermatitis—Methotrexate—psoriatic arthritis	8.35e-05	0.00141	CcSEcCtD
Caffeine—PIK3CB—Immune System—REL—psoriatic arthritis	8.3e-05	0.00207	CbGpPWpGaD
Caffeine—PRKDC—Immune System—HLA-B—psoriatic arthritis	8.1e-05	0.00202	CbGpPWpGaD
Caffeine—PIK3CD—skin of body—psoriatic arthritis	8.05e-05	0.123	CbGeAlD
Caffeine—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriatic arthritis	8.02e-05	0.002	CbGpPWpGaD
Caffeine—PIK3CD—Hemostasis—NOS2—psoriatic arthritis	7.97e-05	0.00199	CbGpPWpGaD
Caffeine—PIK3CD—Innate Immune System—CRP—psoriatic arthritis	7.87e-05	0.00196	CbGpPWpGaD
Caffeine—PIK3CB—Innate Immune System—HLA-B—psoriatic arthritis	7.76e-05	0.00193	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—HLA-C—psoriatic arthritis	7.64e-05	0.0019	CbGpPWpGaD
Caffeine—PIK3CA—Regulation of toll-like receptor signaling pathway—TNF—psoriatic arthritis	7.64e-05	0.0019	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—NOD2—psoriatic arthritis	7.6e-05	0.00189	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—HLA-B—psoriatic arthritis	7.45e-05	0.00186	CbGpPWpGaD
Caffeine—ABCB1—Allograft Rejection—HLA-DRB1—psoriatic arthritis	7.29e-05	0.00182	CbGpPWpGaD
Caffeine—PIK3CD—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	7.24e-05	0.0018	CbGpPWpGaD
Caffeine—PRKDC—Immune System—CRP—psoriatic arthritis	7.16e-05	0.00178	CbGpPWpGaD
Caffeine—PIK3CB—skin of body—psoriatic arthritis	7.02e-05	0.108	CbGeAlD
Caffeine—PIK3CB—Hemostasis—NOS2—psoriatic arthritis	6.95e-05	0.00173	CbGpPWpGaD
Caffeine—PIK3CA—skin of body—psoriatic arthritis	6.94e-05	0.106	CbGeAlD
Caffeine—PIK3CB—Innate Immune System—CRP—psoriatic arthritis	6.86e-05	0.00171	CbGpPWpGaD
Caffeine—PRKDC—Immune System—HLA-DRB1—psoriatic arthritis	6.86e-05	0.00171	CbGpPWpGaD
Caffeine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriatic arthritis	6.65e-05	0.00166	CbGpPWpGaD
Caffeine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	6.65e-05	0.00166	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—REL—psoriatic arthritis	6.54e-05	0.00163	CbGpPWpGaD
Caffeine—PRKDC—tendon—psoriatic arthritis	6.53e-05	0.1	CbGeAlD
Caffeine—PIK3CD—Immune System—NOD2—psoriatic arthritis	6.45e-05	0.00161	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	6.31e-05	0.00157	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—HLA-B—psoriatic arthritis	6.11e-05	0.00152	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—HLA-C—psoriatic arthritis	6.02e-05	0.0015	CbGpPWpGaD
Caffeine—PIK3CA—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	5.93e-05	0.00148	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—HLA-B—psoriatic arthritis	5.87e-05	0.00146	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—NOD2—psoriatic arthritis	5.62e-05	0.0014	CbGpPWpGaD
Caffeine—PIK3CA—Hemostasis—NOS2—psoriatic arthritis	5.47e-05	0.00136	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—CRP—psoriatic arthritis	5.41e-05	0.00135	CbGpPWpGaD
Caffeine—PIK3CB—tendon—psoriatic arthritis	5.34e-05	0.0819	CbGeAlD
Caffeine—RYR1—tendon—psoriatic arthritis	5.29e-05	0.081	CbGeAlD
Caffeine—PIK3CA—tendon—psoriatic arthritis	5.29e-05	0.081	CbGeAlD
Caffeine—PIK3CD—Immune System—HLA-B—psoriatic arthritis	5.19e-05	0.00129	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	4.97e-05	0.00124	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—CRP—psoriatic arthritis	4.58e-05	0.00114	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—HLA-B—psoriatic arthritis	4.52e-05	0.00113	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—NOD2—psoriatic arthritis	4.43e-05	0.0011	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—HLA-DRB1—psoriatic arthritis	4.39e-05	0.00109	CbGpPWpGaD
Caffeine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriatic arthritis	4.24e-05	0.00106	CbGpPWpGaD
Caffeine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	4.24e-05	0.00106	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—CRP—psoriatic arthritis	3.99e-05	0.000995	CbGpPWpGaD
Caffeine—PIK3CD—Disease—NOS2—psoriatic arthritis	3.86e-05	0.000961	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—HLA-DRB1—psoriatic arthritis	3.83e-05	0.000953	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—HLA-B—psoriatic arthritis	3.56e-05	0.000887	CbGpPWpGaD
Caffeine—ABCB1—Allograft Rejection—TNF—psoriatic arthritis	3.45e-05	0.000858	CbGpPWpGaD
Caffeine—PIK3CB—Disease—NOS2—psoriatic arthritis	3.36e-05	0.000838	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—CRP—psoriatic arthritis	3.15e-05	0.000784	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—HLA-DRB1—psoriatic arthritis	3.01e-05	0.000751	CbGpPWpGaD
Caffeine—ADORA1—tendon—psoriatic arthritis	2.79e-05	0.0428	CbGeAlD
Caffeine—PIK3CA—Disease—NOS2—psoriatic arthritis	2.65e-05	0.00066	CbGpPWpGaD
Caffeine—CYP1B1—skin of body—psoriatic arthritis	2.33e-05	0.0357	CbGeAlD
Caffeine—PDE4B—tendon—psoriatic arthritis	2.07e-05	0.0317	CbGeAlD
Caffeine—CYP1B1—tendon—psoriatic arthritis	1.77e-05	0.0271	CbGeAlD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	1.7e-05	0.000424	CbGpPWpGaD
Caffeine—CYP1A1—skin of body—psoriatic arthritis	1.65e-05	0.0252	CbGeAlD
Caffeine—CYP2E1—tendon—psoriatic arthritis	1.14e-05	0.0175	CbGeAlD
